EP06.03-08 Clinical Study to Molecularly Profile Filipino Lung Adenocarcinoma

Lung cancer is the leading cause of cancer death worldwide with lung adenocarcinoma accounting for 40% of cases. Molecular profiling of tumor samples helps in the diagnosis and therapeutic targeting for improved patient outcomes. This clinical study was conducted to determine the molecular profile of Filipino patients with lung adenocarcinoma.